The anxiety and low mood that arrived in my mid-forties felt completely disconnected from anything hormonal — it felt chemical, because it was. What nobody told me is that estrogen is basically the supervisor of your serotonin factory, and when it leaves, the whole operation gets chaotic. Once that clicked, the bad days stopped feeling like a personal failing and started feeling like a physiology problem — which is a completely different thing.
Learn more about Rose →Serotonin doesn't appear from nowhere — it's synthesized from the amino acid tryptophan via an enzyme called tryptophan hydroxylase (TPH2), primarily in the raphe nuclei of the brainstem. Estrogen increases the expression of the gene encoding TPH2, meaning higher estrogen levels genuinely produce more of the enzyme that makes serotonin. When estrogen falls in perimenopause, TPH2 expression drops with it, and the brain's serotonin manufacturing capacity shrinks accordingly.
Once serotonin is released into a synapse, its mood-stabilizing effect depends on how long it stays available before being cleared away by the serotonin transporter (SERT). Estrogen suppresses SERT activity, which means more estrogen keeps serotonin in the synapse longer and amplifies its effect. As estrogen declines, SERT activity increases, serotonin is cleared faster, and the signal is weaker — a double blow on top of reduced production.
Even if some serotonin is present, it needs functional receptors to deliver its message — and estrogen modulates the density and sensitivity of several key serotonin receptor subtypes, particularly 5-HT2A receptors in the prefrontal cortex. Research using PET imaging has shown measurable reductions in serotonin receptor binding in postmenopausal women compared to premenopausal women. This means the serotonin system becomes less responsive at the receiving end, compounding both the production and clearance problems.
Tryptophan doesn't automatically become serotonin — it sits at a metabolic crossroads, and under inflammatory or stress conditions, an enzyme called indoleamine 2,3-dioxygenase (IDO) redirects it down the kynurenine pathway instead, where it produces compounds associated with neuroinflammation and even depression. Perimenopause is associated with a low-grade increase in systemic inflammation, which can shift tryptophan away from serotonin synthesis and toward this less-friendly route. This means stress and inflammation during perimenopause don't just feel bad — they actively steal the raw material needed to make serotonin.
Selective serotonin reuptake inhibitors (SSRIs) work by blocking SERT, the same transporter that estrogen suppresses naturally — so they mimic one part of estrogen's serotonin-protective role. This is why SSRIs can offer meaningful mood support during perimenopause and are a legitimate treatment option. However, SSRIs do nothing to restore serotonin production (TPH2 activity) or receptor sensitivity, which means they're addressing one dimension of a multi-dimensional problem — an important nuance for women who find SSRIs only partially helpful.
Serotonin is the precursor to melatonin, which means a brain producing less serotonin also produces less melatonin — directly worsening the sleep disruption already caused by night sweats and hormonal flux. Poor sleep independently reduces tryptophan availability to the brain by altering large neutral amino acid transport across the blood-brain barrier. The result is a self-reinforcing loop: estrogen loss impairs serotonin, serotonin loss impairs sleep, and poor sleep impairs serotonin further.
Tryptophan is an essential amino acid found in foods like turkey, eggs, dairy, tofu, and seeds, and dietary intake does influence brain serotonin levels — but with a significant catch. Tryptophan competes with other large neutral amino acids (LNAAs) for the same transporter into the brain, so eating high-protein meals can actually reduce tryptophan's brain entry even when total intake is adequate. Consuming tryptophan-containing foods alongside carbohydrates — which trigger insulin and temporarily lower competing amino acids in the blood — is the strategy that actually increases tryptophan's access to the brain.
Multiple studies, including neuroimaging research, have shown that estrogen replacement partially restores TPH2 expression, suppresses SERT activity, and improves serotonin receptor binding — essentially re-engaging the regulatory role estrogen played before perimenopause. The SWAN study and other longitudinal research consistently show lower rates of depressive symptoms in women using hormone therapy compared to those who are not. This doesn't make HRT the right choice for every woman, but it does explain mechanistically why it can be so effective for mood — it's not sedation or mood masking, it's genuinely restoring the underlying chemistry.
Rose covers every symptom, supplement, and condition in full detail — evidence-graded and agenda-free.
Rose is a free, evidence-based reference built for women navigating perimenopause and menopause. No ads. No products to sell. No agenda. Just honest answers — because every woman in this season deserves a trusted friend who has done the research.